Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Patient Preference × Opdualag × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 5 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Recurrence 1 Patient Preference 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1 Brain Neoplasms 1

Interventions

Opdualag 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06101134 2025-04-14

A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Bristol-Myers Squibb

Phase 2 Active not recruiting

Melanoma, Neoplasm Metastasis, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon ⚡